Call to screen patients with cancer for hepatitis B

Several thousand patients a year could be at risk of reactivated infection

All patients about to receive cancer treatment for haematological or solid tumours should be tested for hepatitis B virus (HBV) due to the risk of immunosuppressive treatment reactivating infection, specialists say.